Webinar: Molecules to Medicines

Ted Broughton, Senior Director of Global Health Economics and Outcomes Research at Pfizer leads this webinar introducing the entire drug development process. In 45 minutes he covers discovery, preclinical testing, the three phases of clinical trials, regulatory and reimbursement approval, and what happens after a drug becomes widely available. Why are new drugs so expensive? Why does research attention flow so unevenly? Obesity draws breakthrough after breakthrough and enormous investment, while antibiotics struggle for viability despite a looming infectious disease crisis.

Every medicine in your bathroom cabinet, and every one keeping a patient alive through an IV, began as one molecule among millions. Getting there took a decade and a billion dollars. Most molecules that start the journey never finish it. Understanding why reveals how modern medicine works and why some health problems attract more attention than others.

Whether you're a medical scientist or otherwise curious about where your medicines come from, you'll leave with a clearer picture of the scientific, economic, and now AI forces that drive it all.

If you're not able to see the webinar recording and slides above you can access the recording here and slides here.